News
There could be new hope for people aiming to fight obesity following a research breakthrough identifying certain microproteins that store fat.In findings published in the Proceedings of the National ...
U.S. heart health groups say nearly half of Americans should receive earlier treatment for high blood pressure, including lifestyle changes and medications.
A recent study aimed to assess evidence on the safety and complications of preoperative glucagon-like peptide-1 (GLP-1) ...
High blood pressure (including stage 1 or stage 2 hypertension) affects nearly half (46.7%) of all adults in the U.S.
Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop ...
The NHS will prescribe the weight-loss jab Mounjaro to more people in response to a dramatic price increase for private ...
Weight-loss interventions before IVF increased pregnancy rates and pregnancies resulting from unassisted conception in women with obesity.
Eli Lilly's experimental GLP-1 pill shows promise in a Phase Three trial, helping users lose an average of 12% of body weight, potentially transforming diabetes and obesity treatment.
Doctors and many patients say GLP-1 drugs can help solve the growing problem of obesity. But some bristle at the thought that obesity is a problem at all.
Texas Tech University researchers conducted a comprehensive analysis of available research on the relationship between ...
Eli Lilly plans to increase prices of medicines in Europe and other developed markets “in order to make them lower” in the ...
Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results